GRL0617 is a selective and competitive noncovalent inhibitor of severe acute respiratory syndrome (SARS-CoV) papain-like protease (PLpro), with an IC50 of 0.6 µM and a Ki value of 0.49 µM. GRL0617 also inhibits SARS-CoV with an EC50 of 14.5 µM. GRL0617 can be used for the research of severe acute respiratory syndrome[1].
Molecular Weight:
304.39
Purity:
99.62
CAS Number:
[1093070-16-6]
Formula:
C20H20N2O
Target:
Deubiquitinase,SARS-CoV
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
